In this issue: Risk of serious infections with systemic psoriasis treatments
Long-term safety of guselkumab in moderate-to-severe psoriasis
Predictors of biologic therapy effectiveness in psoriasis
Low long-term rates of immunogenicity with secukinumab
Incidental findings with FDG PET/CT in healthy psoriasis patients
Inflammatory diet not a risk for psoriasis, PsA or atopic dermatitis
No increased risk of skin cancer with long-term NB-UVB
PEST for detecting PsA
Socioeconomic status and anxiety-depression comorbidity in psoriasis
Prevalence of IBD in Japanese psoriatic patients
Please login below to download this issue (PDF)